Combinatory Treatment with Oseltamivir and Itraconazole Targeting Both Virus and Host Factors in Influenza A Virus Infection
Influenza virus infections and their associated morbidity and mortality are a major threat to global health. Vaccination is an effective influenza prevention measure; however, the effectiveness is challenged by the rapid changes in the influenza virus genome leading to viral adaptation. Emerging vir...
Main Authors: | Sebastian Schloer, Jonas Goretzko, Stephan Pleschka, Stephan Ludwig, Ursula Rescher |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/12/7/703 |
Similar Items
-
Occurrence and characterization of oseltamivir-resistant influenza virus in children between 2007-2008 and 2008-2009 seasons
by: Seoung Geun Kim, et al.
Published: (2013-04-01) -
Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus
by: Mariana Baz, et al.
Published: (2018-11-01) -
Effect of an Echinacea-Based Hot Drink Versus Oseltamivir in Influenza Treatment: A Randomized, Double-Blind, Double-Dummy, Multicenter, Noninferiority Clinical Trial
by: Karel Rauš, et al.
Published: (2015-12-01) -
Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
by: Chiara Medaglia, et al.
Published: (2021-06-01) -
Oseltamivir Is Effective against 1918 Influenza Virus Infection of Macaques but Vulnerable to Escape
by: Friederike Feldmann, et al.
Published: (2019-10-01)